nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—systemic lupus erythematosus	0.375	1	CbGaD
Ketorolac—PTGS2—Dapsone—systemic lupus erythematosus	0.106	0.257	CbGbCtD
Ketorolac—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0923	0.223	CbGbCtD
Ketorolac—PTGS1—Dapsone—systemic lupus erythematosus	0.0899	0.217	CbGbCtD
Ketorolac—PTGS2—Betamethasone—systemic lupus erythematosus	0.0792	0.191	CbGbCtD
Ketorolac—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0461	0.111	CbGbCtD
Ketorolac—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000595	0.159	CbGdCrCtD
Ketorolac—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000585	0.156	CbGdCrCtD
Ketorolac—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000585	0.156	CbGdCrCtD
Ketorolac—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000572	0.153	CbGdCrCtD
Ketorolac—Tiaprofenic acid—PTGS2—systemic lupus erythematosus	0.000449	0.169	CrCbGaD
Ketorolac—PTGS1—endothelium—systemic lupus erythematosus	0.00044	0.11	CbGeAlD
Ketorolac—Nepafenac—PTGS2—systemic lupus erythematosus	0.000427	0.16	CrCbGaD
Ketorolac—PTGS2—endothelium—systemic lupus erythematosus	0.00042	0.105	CbGeAlD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.00042	0.0932	CbGpPWpGaD
Ketorolac—Fenbufen—PTGS2—systemic lupus erythematosus	0.000408	0.153	CrCbGaD
Ketorolac—PTGS1—blood plasma—systemic lupus erythematosus	0.00039	0.0978	CbGeAlD
Ketorolac—PTGS2—blood plasma—systemic lupus erythematosus	0.000373	0.0935	CbGeAlD
Ketorolac—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000359	0.0958	CbGdCrCtD
Ketorolac—Tolmetin—PTGS2—systemic lupus erythematosus	0.000355	0.133	CrCbGaD
Ketorolac—Salsalate—PTGS2—systemic lupus erythematosus	0.000355	0.133	CrCbGaD
Ketorolac—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000353	0.0943	CbGdCrCtD
Ketorolac—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000353	0.0943	CbGdCrCtD
Ketorolac—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000345	0.0921	CbGdCrCtD
Ketorolac—Suprofen—PTGS2—systemic lupus erythematosus	0.00034	0.128	CrCbGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.000333	0.074	CbGpPWpGaD
Ketorolac—PTGS1—connective tissue—systemic lupus erythematosus	0.000208	0.0521	CbGeAlD
Ketorolac—PTGS2—connective tissue—systemic lupus erythematosus	0.000199	0.0498	CbGeAlD
Ketorolac—PTGS1—skin of body—systemic lupus erythematosus	0.000188	0.047	CbGeAlD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—systemic lupus erythematosus	0.000184	0.0407	CbGpPWpGaD
Ketorolac—PTGS2—skin of body—systemic lupus erythematosus	0.000179	0.0449	CbGeAlD
Ketorolac—PTGS1—kidney—systemic lupus erythematosus	0.000177	0.0443	CbGeAlD
Ketorolac—Ketoprofen—PTGS2—systemic lupus erythematosus	0.000173	0.065	CrCbGaD
Ketorolac—PTGS2—kidney—systemic lupus erythematosus	0.000169	0.0424	CbGeAlD
Ketorolac—PTGS2—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.00016	0.0355	CbGpPWpGaD
Ketorolac—Ketoprofen—ALB—systemic lupus erythematosus	0.000154	0.0579	CrCbGaD
Ketorolac—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000145	0.0364	CbGeAlD
Ketorolac—PTGS1—tendon—systemic lupus erythematosus	0.000143	0.0358	CbGeAlD
Ketorolac—PTGS2—Spinal Cord Injury—TNFSF13B—systemic lupus erythematosus	0.000137	0.0303	CbGpPWpGaD
Ketorolac—PTGS2—tendon—systemic lupus erythematosus	0.000137	0.0342	CbGeAlD
Ketorolac—PTGS2—bone marrow—systemic lupus erythematosus	0.000132	0.0331	CbGeAlD
Ketorolac—PTGS1—lung—systemic lupus erythematosus	0.000125	0.0314	CbGeAlD
Ketorolac—PTGS2—lung—systemic lupus erythematosus	0.00012	0.03	CbGeAlD
Ketorolac—PTGS1—nervous system—systemic lupus erythematosus	0.000116	0.0291	CbGeAlD
Ketorolac—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000114	0.0253	CbGpPWpGaD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000112	0.0249	CbGpPWpGaD
Ketorolac—PTGS1—central nervous system—systemic lupus erythematosus	0.000112	0.028	CbGeAlD
Ketorolac—PTGS2—nervous system—systemic lupus erythematosus	0.000111	0.0278	CbGeAlD
Ketorolac—PTGS2—central nervous system—systemic lupus erythematosus	0.000107	0.0268	CbGeAlD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	9.94e-05	0.0221	CbGpPWpGaD
Ketorolac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	9.76e-05	0.0217	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	9.28e-05	0.0206	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	9.05e-05	0.0201	CbGpPWpGaD
Ketorolac—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	8.92e-05	0.0198	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	7.68e-05	0.017	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	7.65e-05	0.017	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	7.47e-05	0.0166	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	7.14e-05	0.0158	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	6.84e-05	0.0152	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	6.43e-05	0.0143	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	6.39e-05	0.0142	CbGpPWpGaD
Ketorolac—Oedema—Betamethasone—systemic lupus erythematosus	6.35e-05	0.000323	CcSEcCtD
Ketorolac—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	6.35e-05	0.000323	CcSEcCtD
Ketorolac—Oedema—Dexamethasone—systemic lupus erythematosus	6.35e-05	0.000323	CcSEcCtD
Ketorolac—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	6.34e-05	0.0141	CbGpPWpGaD
Ketorolac—Insomnia—Triamcinolone—systemic lupus erythematosus	6.33e-05	0.000322	CcSEcCtD
Ketorolac—Insomnia—Methylprednisolone—systemic lupus erythematosus	6.32e-05	0.000321	CcSEcCtD
Ketorolac—Infection—Dexamethasone—systemic lupus erythematosus	6.31e-05	0.000321	CcSEcCtD
Ketorolac—Infection—Betamethasone—systemic lupus erythematosus	6.31e-05	0.000321	CcSEcCtD
Ketorolac—Ill-defined disorder—Prednisone—systemic lupus erythematosus	6.29e-05	0.00032	CcSEcCtD
Ketorolac—Paraesthesia—Triamcinolone—systemic lupus erythematosus	6.29e-05	0.00032	CcSEcCtD
Ketorolac—Feeling abnormal—Prednisolone—systemic lupus erythematosus	6.27e-05	0.000319	CcSEcCtD
Ketorolac—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	6.27e-05	0.000319	CcSEcCtD
Ketorolac—Visual impairment—Methotrexate—systemic lupus erythematosus	6.27e-05	0.000319	CcSEcCtD
Ketorolac—Anaemia—Prednisone—systemic lupus erythematosus	6.26e-05	0.000319	CcSEcCtD
Ketorolac—Shock—Betamethasone—systemic lupus erythematosus	6.25e-05	0.000318	CcSEcCtD
Ketorolac—Shock—Dexamethasone—systemic lupus erythematosus	6.25e-05	0.000318	CcSEcCtD
Ketorolac—Dyspnoea—Triamcinolone—systemic lupus erythematosus	6.24e-05	0.000318	CcSEcCtD
Ketorolac—Nervous system disorder—Betamethasone—systemic lupus erythematosus	6.23e-05	0.000317	CcSEcCtD
Ketorolac—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	6.23e-05	0.000317	CcSEcCtD
Ketorolac—Agitation—Prednisone—systemic lupus erythematosus	6.23e-05	0.000317	CcSEcCtD
Ketorolac—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.22e-05	0.000316	CcSEcCtD
Ketorolac—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.22e-05	0.000316	CcSEcCtD
Ketorolac—Tachycardia—Betamethasone—systemic lupus erythematosus	6.2e-05	0.000315	CcSEcCtD
Ketorolac—Tachycardia—Dexamethasone—systemic lupus erythematosus	6.2e-05	0.000315	CcSEcCtD
Ketorolac—Angioedema—Prednisone—systemic lupus erythematosus	6.19e-05	0.000315	CcSEcCtD
Ketorolac—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	6.16e-05	0.000314	CcSEcCtD
Ketorolac—Dyspepsia—Triamcinolone—systemic lupus erythematosus	6.16e-05	0.000313	CcSEcCtD
Ketorolac—Erythema multiforme—Methotrexate—systemic lupus erythematosus	6.15e-05	0.000313	CcSEcCtD
Ketorolac—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	6.15e-05	0.000313	CcSEcCtD
Ketorolac—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	6.14e-05	0.000312	CcSEcCtD
Ketorolac—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	6.14e-05	0.000312	CcSEcCtD
Ketorolac—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	6.13e-05	0.000312	CcSEcCtD
Ketorolac—Malaise—Prednisone—systemic lupus erythematosus	6.11e-05	0.000311	CcSEcCtD
Ketorolac—Vertigo—Prednisone—systemic lupus erythematosus	6.09e-05	0.00031	CcSEcCtD
Ketorolac—Eye disorder—Methotrexate—systemic lupus erythematosus	6.08e-05	0.000309	CcSEcCtD
Ketorolac—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	6.08e-05	0.000309	CcSEcCtD
Ketorolac—Syncope—Prednisone—systemic lupus erythematosus	6.08e-05	0.000309	CcSEcCtD
Ketorolac—Tinnitus—Methotrexate—systemic lupus erythematosus	6.07e-05	0.000309	CcSEcCtD
Ketorolac—Anorexia—Betamethasone—systemic lupus erythematosus	6.05e-05	0.000308	CcSEcCtD
Ketorolac—Anorexia—Dexamethasone—systemic lupus erythematosus	6.05e-05	0.000308	CcSEcCtD
Ketorolac—Urticaria—Prednisolone—systemic lupus erythematosus	6.05e-05	0.000308	CcSEcCtD
Ketorolac—Cardiac disorder—Methotrexate—systemic lupus erythematosus	6.04e-05	0.000307	CcSEcCtD
Ketorolac—Fatigue—Triamcinolone—systemic lupus erythematosus	6.03e-05	0.000307	CcSEcCtD
Ketorolac—Fatigue—Methylprednisolone—systemic lupus erythematosus	6.02e-05	0.000306	CcSEcCtD
Ketorolac—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.01e-05	0.000306	CcSEcCtD
Ketorolac—Asthenia—Cyclosporine—systemic lupus erythematosus	6e-05	0.000305	CcSEcCtD
Ketorolac—Pain—Triamcinolone—systemic lupus erythematosus	5.99e-05	0.000305	CcSEcCtD
Ketorolac—Loss of consciousness—Prednisone—systemic lupus erythematosus	5.96e-05	0.000303	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	5.95e-05	0.0132	CbGpPWpGaD
Ketorolac—Hypotension—Dexamethasone—systemic lupus erythematosus	5.93e-05	0.000302	CcSEcCtD
Ketorolac—Hypotension—Betamethasone—systemic lupus erythematosus	5.93e-05	0.000302	CcSEcCtD
Ketorolac—Pruritus—Cyclosporine—systemic lupus erythematosus	5.92e-05	0.000301	CcSEcCtD
Ketorolac—Urticaria—Hydrocortisone—systemic lupus erythematosus	5.91e-05	0.0003	CcSEcCtD
Ketorolac—Angiopathy—Methotrexate—systemic lupus erythematosus	5.9e-05	0.0003	CcSEcCtD
Ketorolac—Immune system disorder—Methotrexate—systemic lupus erythematosus	5.88e-05	0.000299	CcSEcCtD
Ketorolac—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.88e-05	0.000299	CcSEcCtD
Ketorolac—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.88e-05	0.000299	CcSEcCtD
Ketorolac—Convulsion—Prednisone—systemic lupus erythematosus	5.87e-05	0.000299	CcSEcCtD
Ketorolac—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	5.86e-05	0.000298	CcSEcCtD
Ketorolac—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.85e-05	0.000298	CcSEcCtD
Ketorolac—Hypertension—Prednisone—systemic lupus erythematosus	5.85e-05	0.000298	CcSEcCtD
Ketorolac—Chills—Methotrexate—systemic lupus erythematosus	5.84e-05	0.000297	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	5.79e-05	0.000294	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	5.79e-05	0.000294	CcSEcCtD
Ketorolac—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.77e-05	0.000294	CcSEcCtD
Ketorolac—Arthralgia—Prednisone—systemic lupus erythematosus	5.77e-05	0.000294	CcSEcCtD
Ketorolac—Myalgia—Prednisone—systemic lupus erythematosus	5.77e-05	0.000294	CcSEcCtD
Ketorolac—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	5.77e-05	0.000293	CcSEcCtD
Ketorolac—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	5.76e-05	0.000293	CcSEcCtD
Ketorolac—Anxiety—Prednisone—systemic lupus erythematosus	5.75e-05	0.000293	CcSEcCtD
Ketorolac—Alopecia—Methotrexate—systemic lupus erythematosus	5.75e-05	0.000293	CcSEcCtD
Ketorolac—Insomnia—Dexamethasone—systemic lupus erythematosus	5.74e-05	0.000292	CcSEcCtD
Ketorolac—Insomnia—Betamethasone—systemic lupus erythematosus	5.74e-05	0.000292	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	5.73e-05	0.000292	CcSEcCtD
Ketorolac—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.72e-05	0.000291	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.71e-05	0.000291	CcSEcCtD
Ketorolac—Paraesthesia—Betamethasone—systemic lupus erythematosus	5.7e-05	0.00029	CcSEcCtD
Ketorolac—Paraesthesia—Dexamethasone—systemic lupus erythematosus	5.7e-05	0.00029	CcSEcCtD
Ketorolac—Discomfort—Prednisone—systemic lupus erythematosus	5.7e-05	0.00029	CcSEcCtD
Ketorolac—Mental disorder—Methotrexate—systemic lupus erythematosus	5.7e-05	0.00029	CcSEcCtD
Ketorolac—Malnutrition—Methotrexate—systemic lupus erythematosus	5.66e-05	0.000288	CcSEcCtD
Ketorolac—Erythema—Methotrexate—systemic lupus erythematosus	5.66e-05	0.000288	CcSEcCtD
Ketorolac—Hypersensitivity—Prednisolone—systemic lupus erythematosus	5.61e-05	0.000285	CcSEcCtD
Ketorolac—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.59e-05	0.000284	CcSEcCtD
Ketorolac—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.59e-05	0.000284	CcSEcCtD
Ketorolac—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.58e-05	0.000284	CcSEcCtD
Ketorolac—Urticaria—Triamcinolone—systemic lupus erythematosus	5.56e-05	0.000283	CcSEcCtD
Ketorolac—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.55e-05	0.000282	CcSEcCtD
Ketorolac—Dysgeusia—Methotrexate—systemic lupus erythematosus	5.55e-05	0.000282	CcSEcCtD
Ketorolac—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.53e-05	0.000282	CcSEcCtD
Ketorolac—Dizziness—Cyclosporine—systemic lupus erythematosus	5.53e-05	0.000281	CcSEcCtD
Ketorolac—Oedema—Prednisone—systemic lupus erythematosus	5.53e-05	0.000281	CcSEcCtD
Ketorolac—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.53e-05	0.000281	CcSEcCtD
Ketorolac—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.52e-05	0.000281	CcSEcCtD
Ketorolac—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.52e-05	0.000281	CcSEcCtD
Ketorolac—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.52e-05	0.000281	CcSEcCtD
Ketorolac—Infection—Prednisone—systemic lupus erythematosus	5.49e-05	0.00028	CcSEcCtD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	5.49e-05	0.0122	CbGpPWpGaD
Ketorolac—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	5.48e-05	0.000279	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	5.48e-05	0.000279	CcSEcCtD
Ketorolac—Back pain—Methotrexate—systemic lupus erythematosus	5.48e-05	0.000279	CcSEcCtD
Ketorolac—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	5.48e-05	0.000279	CcSEcCtD
Ketorolac—Fatigue—Dexamethasone—systemic lupus erythematosus	5.48e-05	0.000279	CcSEcCtD
Ketorolac—Fatigue—Betamethasone—systemic lupus erythematosus	5.48e-05	0.000279	CcSEcCtD
Ketorolac—Shock—Prednisone—systemic lupus erythematosus	5.44e-05	0.000277	CcSEcCtD
Ketorolac—Pain—Dexamethasone—systemic lupus erythematosus	5.43e-05	0.000276	CcSEcCtD
Ketorolac—Pain—Betamethasone—systemic lupus erythematosus	5.43e-05	0.000276	CcSEcCtD
Ketorolac—Nervous system disorder—Prednisone—systemic lupus erythematosus	5.42e-05	0.000276	CcSEcCtD
Ketorolac—Tachycardia—Prednisone—systemic lupus erythematosus	5.4e-05	0.000275	CcSEcCtD
Ketorolac—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.4e-05	0.000275	CcSEcCtD
Ketorolac—Skin disorder—Prednisone—systemic lupus erythematosus	5.37e-05	0.000273	CcSEcCtD
Ketorolac—Hyperhidrosis—Prednisone—systemic lupus erythematosus	5.35e-05	0.000272	CcSEcCtD
Ketorolac—Vision blurred—Methotrexate—systemic lupus erythematosus	5.34e-05	0.000272	CcSEcCtD
Ketorolac—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.33e-05	0.000271	CcSEcCtD
Ketorolac—Vomiting—Cyclosporine—systemic lupus erythematosus	5.32e-05	0.000271	CcSEcCtD
Ketorolac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	5.31e-05	0.0118	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	5.27e-05	0.0117	CbGpPWpGaD
Ketorolac—Rash—Cyclosporine—systemic lupus erythematosus	5.27e-05	0.000268	CcSEcCtD
Ketorolac—Anorexia—Prednisone—systemic lupus erythematosus	5.27e-05	0.000268	CcSEcCtD
Ketorolac—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.27e-05	0.000268	CcSEcCtD
Ketorolac—Pruritus—Hydrocortisone—systemic lupus erythematosus	5.26e-05	0.000268	CcSEcCtD
Ketorolac—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	5.25e-05	0.000267	CcSEcCtD
Ketorolac—Headache—Cyclosporine—systemic lupus erythematosus	5.24e-05	0.000267	CcSEcCtD
Ketorolac—Anaemia—Methotrexate—systemic lupus erythematosus	5.23e-05	0.000266	CcSEcCtD
Ketorolac—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.23e-05	0.000266	CcSEcCtD
Ketorolac—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.23e-05	0.000266	CcSEcCtD
Ketorolac—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.19e-05	0.000264	CcSEcCtD
Ketorolac—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.19e-05	0.000264	CcSEcCtD
Ketorolac—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.19e-05	0.000264	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	5.16e-05	0.0115	CbGpPWpGaD
Ketorolac—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.16e-05	0.000262	CcSEcCtD
Ketorolac—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.15e-05	0.000262	CcSEcCtD
Ketorolac—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.14e-05	0.000262	CcSEcCtD
Ketorolac—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.14e-05	0.000262	CcSEcCtD
Ketorolac—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.11e-05	0.00026	CcSEcCtD
Ketorolac—Malaise—Methotrexate—systemic lupus erythematosus	5.11e-05	0.00026	CcSEcCtD
Ketorolac—Vertigo—Methotrexate—systemic lupus erythematosus	5.09e-05	0.000259	CcSEcCtD
Ketorolac—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.09e-05	0.000259	CcSEcCtD
Ketorolac—Leukopenia—Methotrexate—systemic lupus erythematosus	5.07e-05	0.000258	CcSEcCtD
Ketorolac—Urticaria—Dexamethasone—systemic lupus erythematosus	5.05e-05	0.000257	CcSEcCtD
Ketorolac—Urticaria—Betamethasone—systemic lupus erythematosus	5.05e-05	0.000257	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	5.04e-05	0.000256	CcSEcCtD
Ketorolac—Dizziness—Prednisolone—systemic lupus erythematosus	5.03e-05	0.000256	CcSEcCtD
Ketorolac—Asthenia—Triamcinolone—systemic lupus erythematosus	5.02e-05	0.000256	CcSEcCtD
Ketorolac—Abdominal pain—Dexamethasone—systemic lupus erythematosus	5.02e-05	0.000255	CcSEcCtD
Ketorolac—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.02e-05	0.000255	CcSEcCtD
Ketorolac—Abdominal pain—Betamethasone—systemic lupus erythematosus	5.02e-05	0.000255	CcSEcCtD
Ketorolac—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.02e-05	0.000255	CcSEcCtD
Ketorolac—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.01e-05	0.000255	CcSEcCtD
Ketorolac—Insomnia—Prednisone—systemic lupus erythematosus	5e-05	0.000255	CcSEcCtD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.97e-05	0.011	CbGpPWpGaD
Ketorolac—Nausea—Cyclosporine—systemic lupus erythematosus	4.97e-05	0.000253	CcSEcCtD
Ketorolac—Paraesthesia—Prednisone—systemic lupus erythematosus	4.97e-05	0.000253	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	4.97e-05	0.011	CbGpPWpGaD
Ketorolac—Pruritus—Triamcinolone—systemic lupus erythematosus	4.95e-05	0.000252	CcSEcCtD
Ketorolac—Cough—Methotrexate—systemic lupus erythematosus	4.94e-05	0.000251	CcSEcCtD
Ketorolac—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.94e-05	0.000251	CcSEcCtD
Ketorolac—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.92e-05	0.00025	CcSEcCtD
Ketorolac—Convulsion—Methotrexate—systemic lupus erythematosus	4.91e-05	0.00025	CcSEcCtD
Ketorolac—Dyspepsia—Prednisone—systemic lupus erythematosus	4.87e-05	0.000248	CcSEcCtD
Ketorolac—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.85e-05	0.000247	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	4.83e-05	0.0107	CbGpPWpGaD
Ketorolac—Arthralgia—Methotrexate—systemic lupus erythematosus	4.82e-05	0.000245	CcSEcCtD
Ketorolac—Chest pain—Methotrexate—systemic lupus erythematosus	4.82e-05	0.000245	CcSEcCtD
Ketorolac—Myalgia—Methotrexate—systemic lupus erythematosus	4.82e-05	0.000245	CcSEcCtD
Ketorolac—Decreased appetite—Prednisone—systemic lupus erythematosus	4.81e-05	0.000245	CcSEcCtD
Ketorolac—Rash—Prednisolone—systemic lupus erythematosus	4.8e-05	0.000244	CcSEcCtD
Ketorolac—Dermatitis—Prednisolone—systemic lupus erythematosus	4.79e-05	0.000244	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	4.79e-05	0.000244	CcSEcCtD
Ketorolac—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	4.78e-05	0.0106	CbGpPWpGaD
Ketorolac—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.78e-05	0.000243	CcSEcCtD
Ketorolac—Fatigue—Prednisone—systemic lupus erythematosus	4.77e-05	0.000243	CcSEcCtD
Ketorolac—Headache—Prednisolone—systemic lupus erythematosus	4.77e-05	0.000243	CcSEcCtD
Ketorolac—Discomfort—Methotrexate—systemic lupus erythematosus	4.76e-05	0.000242	CcSEcCtD
Ketorolac—Constipation—Prednisone—systemic lupus erythematosus	4.73e-05	0.000241	CcSEcCtD
Ketorolac—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.73e-05	0.00024	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	4.71e-05	0.0105	CbGpPWpGaD
Ketorolac—Rash—Hydrocortisone—systemic lupus erythematosus	4.69e-05	0.000238	CcSEcCtD
Ketorolac—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.68e-05	0.000238	CcSEcCtD
Ketorolac—Confusional state—Methotrexate—systemic lupus erythematosus	4.66e-05	0.000237	CcSEcCtD
Ketorolac—Headache—Hydrocortisone—systemic lupus erythematosus	4.66e-05	0.000237	CcSEcCtD
Ketorolac—Dizziness—Triamcinolone—systemic lupus erythematosus	4.63e-05	0.000236	CcSEcCtD
Ketorolac—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.62e-05	0.000235	CcSEcCtD
Ketorolac—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.62e-05	0.000235	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	4.62e-05	0.0102	CbGpPWpGaD
Ketorolac—Infection—Methotrexate—systemic lupus erythematosus	4.59e-05	0.000234	CcSEcCtD
Ketorolac—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Ketorolac—Asthenia—Dexamethasone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Ketorolac—Asthenia—Betamethasone—systemic lupus erythematosus	4.56e-05	0.000232	CcSEcCtD
Ketorolac—Nervous system disorder—Methotrexate—systemic lupus erythematosus	4.53e-05	0.000231	CcSEcCtD
Ketorolac—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.53e-05	0.00023	CcSEcCtD
Ketorolac—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.52e-05	0.00023	CcSEcCtD
Ketorolac—Nausea—Prednisolone—systemic lupus erythematosus	4.52e-05	0.00023	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	4.51e-05	0.01	CbGpPWpGaD
Ketorolac—Pruritus—Dexamethasone—systemic lupus erythematosus	4.49e-05	0.000229	CcSEcCtD
Ketorolac—Pruritus—Betamethasone—systemic lupus erythematosus	4.49e-05	0.000229	CcSEcCtD
Ketorolac—Skin disorder—Methotrexate—systemic lupus erythematosus	4.49e-05	0.000228	CcSEcCtD
Ketorolac—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000227	CcSEcCtD
Ketorolac—Vomiting—Triamcinolone—systemic lupus erythematosus	4.45e-05	0.000226	CcSEcCtD
Ketorolac—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.44e-05	0.000226	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	4.43e-05	0.00982	CbGpPWpGaD
Ketorolac—Nausea—Hydrocortisone—systemic lupus erythematosus	4.42e-05	0.000225	CcSEcCtD
Ketorolac—Rash—Triamcinolone—systemic lupus erythematosus	4.41e-05	0.000225	CcSEcCtD
Ketorolac—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.41e-05	0.000224	CcSEcCtD
Ketorolac—Anorexia—Methotrexate—systemic lupus erythematosus	4.41e-05	0.000224	CcSEcCtD
Ketorolac—Rash—Methylprednisolone—systemic lupus erythematosus	4.4e-05	0.000224	CcSEcCtD
Ketorolac—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.4e-05	0.000224	CcSEcCtD
Ketorolac—Urticaria—Prednisone—systemic lupus erythematosus	4.39e-05	0.000224	CcSEcCtD
Ketorolac—Headache—Triamcinolone—systemic lupus erythematosus	4.38e-05	0.000223	CcSEcCtD
Ketorolac—Headache—Methylprednisolone—systemic lupus erythematosus	4.38e-05	0.000223	CcSEcCtD
Ketorolac—Body temperature increased—Prednisone—systemic lupus erythematosus	4.37e-05	0.000222	CcSEcCtD
Ketorolac—Abdominal pain—Prednisone—systemic lupus erythematosus	4.37e-05	0.000222	CcSEcCtD
Ketorolac—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.35e-05	0.000221	CcSEcCtD
Ketorolac—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.35e-05	0.000221	CcSEcCtD
Ketorolac—Hypotension—Methotrexate—systemic lupus erythematosus	4.32e-05	0.00022	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	4.21e-05	0.000214	CcSEcCtD
Ketorolac—Dizziness—Dexamethasone—systemic lupus erythematosus	4.2e-05	0.000214	CcSEcCtD
Ketorolac—Dizziness—Betamethasone—systemic lupus erythematosus	4.2e-05	0.000214	CcSEcCtD
Ketorolac—Insomnia—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000213	CcSEcCtD
Ketorolac—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	4.17e-05	0.00925	CbGpPWpGaD
Ketorolac—Nausea—Triamcinolone—systemic lupus erythematosus	4.16e-05	0.000212	CcSEcCtD
Ketorolac—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.15e-05	0.000211	CcSEcCtD
Ketorolac—Nausea—Methylprednisolone—systemic lupus erythematosus	4.15e-05	0.000211	CcSEcCtD
Ketorolac—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.12e-05	0.00021	CcSEcCtD
Ketorolac—Somnolence—Methotrexate—systemic lupus erythematosus	4.11e-05	0.000209	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	4.1e-05	0.0091	CbGpPWpGaD
Ketorolac—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.07e-05	0.000207	CcSEcCtD
Ketorolac—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.07e-05	0.000207	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	4.04e-05	0.00898	CbGpPWpGaD
Ketorolac—Vomiting—Betamethasone—systemic lupus erythematosus	4.04e-05	0.000205	CcSEcCtD
Ketorolac—Vomiting—Dexamethasone—systemic lupus erythematosus	4.04e-05	0.000205	CcSEcCtD
Ketorolac—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.02e-05	0.000204	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	4.01e-05	0.00891	CbGpPWpGaD
Ketorolac—Rash—Betamethasone—systemic lupus erythematosus	4e-05	0.000204	CcSEcCtD
Ketorolac—Rash—Dexamethasone—systemic lupus erythematosus	4e-05	0.000204	CcSEcCtD
Ketorolac—Dermatitis—Betamethasone—systemic lupus erythematosus	4e-05	0.000204	CcSEcCtD
Ketorolac—Dermatitis—Dexamethasone—systemic lupus erythematosus	4e-05	0.000204	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.99e-05	0.000203	CcSEcCtD
Ketorolac—Fatigue—Methotrexate—systemic lupus erythematosus	3.99e-05	0.000203	CcSEcCtD
Ketorolac—Headache—Dexamethasone—systemic lupus erythematosus	3.98e-05	0.000202	CcSEcCtD
Ketorolac—Headache—Betamethasone—systemic lupus erythematosus	3.98e-05	0.000202	CcSEcCtD
Ketorolac—Asthenia—Prednisone—systemic lupus erythematosus	3.97e-05	0.000202	CcSEcCtD
Ketorolac—Pain—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000201	CcSEcCtD
Ketorolac—Pruritus—Prednisone—systemic lupus erythematosus	3.91e-05	0.000199	CcSEcCtD
Ketorolac—Feeling abnormal—Methotrexate—systemic lupus erythematosus	3.81e-05	0.000194	CcSEcCtD
Ketorolac—Diarrhoea—Prednisone—systemic lupus erythematosus	3.78e-05	0.000193	CcSEcCtD
Ketorolac—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.78e-05	0.000192	CcSEcCtD
Ketorolac—Nausea—Dexamethasone—systemic lupus erythematosus	3.77e-05	0.000192	CcSEcCtD
Ketorolac—Nausea—Betamethasone—systemic lupus erythematosus	3.77e-05	0.000192	CcSEcCtD
Ketorolac—Urticaria—Methotrexate—systemic lupus erythematosus	3.67e-05	0.000187	CcSEcCtD
Ketorolac—Dizziness—Prednisone—systemic lupus erythematosus	3.66e-05	0.000186	CcSEcCtD
Ketorolac—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000186	CcSEcCtD
Ketorolac—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000186	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	3.56e-05	0.0079	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.53e-05	0.00783	CbGpPWpGaD
Ketorolac—Vomiting—Prednisone—systemic lupus erythematosus	3.52e-05	0.000179	CcSEcCtD
Ketorolac—Rash—Prednisone—systemic lupus erythematosus	3.49e-05	0.000177	CcSEcCtD
Ketorolac—Dermatitis—Prednisone—systemic lupus erythematosus	3.48e-05	0.000177	CcSEcCtD
Ketorolac—Headache—Prednisone—systemic lupus erythematosus	3.46e-05	0.000176	CcSEcCtD
Ketorolac—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	3.43e-05	0.00762	CbGpPWpGaD
Ketorolac—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.41e-05	0.000173	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	3.35e-05	0.00743	CbGpPWpGaD
Ketorolac—Asthenia—Methotrexate—systemic lupus erythematosus	3.32e-05	0.000169	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	3.31e-05	0.00734	CbGpPWpGaD
Ketorolac—Nausea—Prednisone—systemic lupus erythematosus	3.29e-05	0.000167	CcSEcCtD
Ketorolac—Pruritus—Methotrexate—systemic lupus erythematosus	3.27e-05	0.000166	CcSEcCtD
Ketorolac—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000161	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	3.09e-05	0.00685	CbGpPWpGaD
Ketorolac—Dizziness—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000156	CcSEcCtD
Ketorolac—Vomiting—Methotrexate—systemic lupus erythematosus	2.94e-05	0.00015	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	2.92e-05	0.00648	CbGpPWpGaD
Ketorolac—Rash—Methotrexate—systemic lupus erythematosus	2.91e-05	0.000148	CcSEcCtD
Ketorolac—Dermatitis—Methotrexate—systemic lupus erythematosus	2.91e-05	0.000148	CcSEcCtD
Ketorolac—Headache—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000147	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	2.83e-05	0.00629	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.75e-05	0.00611	CbGpPWpGaD
Ketorolac—Nausea—Methotrexate—systemic lupus erythematosus	2.75e-05	0.00014	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	2.66e-05	0.0059	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	2.64e-05	0.00587	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.62e-05	0.00581	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	2.59e-05	0.00576	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.56e-05	0.00569	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.49e-05	0.00552	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.45e-05	0.00544	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	2.43e-05	0.00539	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.36e-05	0.00523	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.34e-05	0.00519	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	2.33e-05	0.00518	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	2.24e-05	0.00498	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.2e-05	0.00489	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.18e-05	0.00485	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.04e-05	0.00452	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.02e-05	0.00448	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	2.01e-05	0.00447	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	1.93e-05	0.00428	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	1.89e-05	0.0042	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	1.86e-05	0.00413	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.86e-05	0.00412	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	1.75e-05	0.00389	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	1.73e-05	0.00384	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	1.62e-05	0.00359	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.58e-05	0.00351	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	1.54e-05	0.00341	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.52e-05	0.00338	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.51e-05	0.00336	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	1.47e-05	0.00326	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	1.33e-05	0.00296	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	1.31e-05	0.0029	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	1.24e-05	0.00274	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.22e-05	0.00271	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.2e-05	0.00267	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	1.02e-05	0.00226	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.01e-05	0.00225	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	9.7e-06	0.00215	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	9.51e-06	0.00211	CbGpPWpGaD
Ketorolac—PTGS2—Disease—XRCC6—systemic lupus erythematosus	9.48e-06	0.0021	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.08e-06	0.00201	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	8.38e-06	0.00186	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	8.06e-06	0.00179	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.06e-06	0.00179	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	7.97e-06	0.00177	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	7.67e-06	0.0017	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.55e-06	0.00168	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	6.99e-06	0.00155	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	6.93e-06	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CSK—systemic lupus erythematosus	6.81e-06	0.00151	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.47e-06	0.00144	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	6.41e-06	0.00142	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD247—systemic lupus erythematosus	6.4e-06	0.00142	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	6.4e-06	0.00142	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NCF2—systemic lupus erythematosus	6.23e-06	0.00138	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.76e-06	0.00128	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.09e-06	0.00113	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.04e-06	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JUNB—systemic lupus erythematosus	4.89e-06	0.00109	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.57e-06	0.00102	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	4.52e-06	0.001	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRL—systemic lupus erythematosus	4.5e-06	0.001	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.19e-06	0.00093	CbGpPWpGaD
Ketorolac—PTGS2—Disease—JAK1—systemic lupus erythematosus	3.6e-06	0.0008	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	3.59e-06	0.000796	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CCR5—systemic lupus erythematosus	3.41e-06	0.000758	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.33e-06	0.000739	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	2.85e-06	0.000633	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD80—systemic lupus erythematosus	2.81e-06	0.000623	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—systemic lupus erythematosus	2.57e-06	0.00057	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	2.45e-06	0.000545	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TYK2—systemic lupus erythematosus	2.37e-06	0.000526	CbGpPWpGaD
Ketorolac—PTGS2—Disease—NOS3—systemic lupus erythematosus	2.33e-06	0.000516	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	2.27e-06	0.000503	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	2.24e-06	0.000498	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CD4—systemic lupus erythematosus	2.14e-06	0.000476	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—systemic lupus erythematosus	2.04e-06	0.000452	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	2.02e-06	0.000447	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	1.95e-06	0.000432	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.87e-06	0.000414	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.86e-06	0.000413	CbGpPWpGaD
Ketorolac—PTGS2—Disease—EP300—systemic lupus erythematosus	1.77e-06	0.000393	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.54e-06	0.000341	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.48e-06	0.000329	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—systemic lupus erythematosus	1.16e-06	0.000257	CbGpPWpGaD
